The global language services market is projected to grow at a CAGR of 6.5% (2025-2030), driven by pharma. AI translation tools now achieve 95% accuracy, while 73% of pharma companies invest in RSI for cost-effective, efficient multilingual trials. These technologies are accelerating drug approvals and improving patient outcomes worldwide.